189 related articles for article (PubMed ID: 23370512)
1. [Molecular imaging-based early-phase and exploratory clinical research].
Watanabe Y
Yakugaku Zasshi; 2013; 133(2):187-95. PubMed ID: 23370512
[TBL] [Abstract][Full Text] [Related]
2. [Regulatory authorities expect innovative drug delivery systems (DDS)].
Mori K
Yakugaku Zasshi; 2013; 133(1):73-80. PubMed ID: 23292023
[TBL] [Abstract][Full Text] [Related]
3. [Pharmaceuticals and Medical Devices Agency (PMDA)'s new action for Pharmaceutical Affairs Consultation on Research and Development (R&D) Strategy].
Masuyama K
Yakugaku Zasshi; 2013; 133(2):183-6. PubMed ID: 23370511
[TBL] [Abstract][Full Text] [Related]
4. [Application of pre-clinical PET imaging for drug development].
Tsukada H
Nihon Shinkei Seishin Yakurigaku Zasshi; 2011 Nov; 31(5-6):231-7. PubMed ID: 22256612
[TBL] [Abstract][Full Text] [Related]
5. Matching Chelators to Radiometals for Positron Emission Tomography Imaging- Guided Targeted Drug Delivery.
Deng H; Wang H; Li Z
Curr Drug Targets; 2015; 16(6):610-24. PubMed ID: 26148988
[TBL] [Abstract][Full Text] [Related]
6. Positron emission tomography molecular imaging for drug development.
Matthews PM; Rabiner EA; Passchier J; Gunn RN
Br J Clin Pharmacol; 2012 Feb; 73(2):175-86. PubMed ID: 21838787
[TBL] [Abstract][Full Text] [Related]
7. [In vivo imaging of liposomal small interfering RNA (siRNA) trafficking by positron emission tomography].
Ando H; Yonenaga N; Asai T; Hatanaka K; Koide H; Tsuzuku T; Harada N; Tsukada H; Oku N
Yakugaku Zasshi; 2012; 132(12):1373-81. PubMed ID: 23208044
[TBL] [Abstract][Full Text] [Related]
8. Image-driven pharmacokinetics: nanomedicine concentration across space and time.
Brill DA; MacKay JA
Nanomedicine (Lond); 2015; 10(18):2861-79. PubMed ID: 26370694
[TBL] [Abstract][Full Text] [Related]
9. [Current PMDA Activities for Use of Biomarkers in Drug Evaluation].
Ishiguro A
Yakugaku Zasshi; 2015; 135(5):681-4. PubMed ID: 25948301
[TBL] [Abstract][Full Text] [Related]
10. [Molecular imaging for drug development].
Watanabe Y
Brain Nerve; 2007 Mar; 59(3):209-14. PubMed ID: 17370646
[TBL] [Abstract][Full Text] [Related]
11. Review: PET imaging with macro- and middle-sized molecular probes.
Mukai H; Watanabe Y
Nucl Med Biol; 2021 Jan; 92():156-170. PubMed ID: 32660789
[TBL] [Abstract][Full Text] [Related]
12. Target-specific delivery of peptide-based probes for PET imaging.
Chen K; Conti PS
Adv Drug Deliv Rev; 2010 Aug; 62(11):1005-22. PubMed ID: 20851156
[TBL] [Abstract][Full Text] [Related]
13. [Consideration on molecular imaging technology as a tool for drug research and development].
Yajima K; Nishimura S
Yakugaku Zasshi; 2009 Mar; 129(3):297-304. PubMed ID: 19252387
[TBL] [Abstract][Full Text] [Related]
14. Quantitative evaluation of the improvement in the pharmacokinetics of a nucleic acid drug delivery system by dynamic PET imaging with (18)F-incorporated oligodeoxynucleotides.
Mukai H; Ozaki D; Cui Y; Kuboyama T; Yamato-Nagata H; Onoe K; Takahashi M; Wada Y; Imanishi T; Kodama T; Obika S; Suzuki M; Doi H; Watanabe Y
J Control Release; 2014 Apr; 180():92-9. PubMed ID: 24566256
[TBL] [Abstract][Full Text] [Related]
15. A rational regulatory approach for positron emission tomography imaging probes: from "first in man" to NDA approval and reimbursement.
Barrio JR; Marcus CS; Hung JC; Keppler JS
Mol Imaging Biol; 2004; 6(6):361-7. PubMed ID: 15564146
[TBL] [Abstract][Full Text] [Related]
16. [Molecular imaging for drug development].
Watanabe Y
Nihon Rinsho; 2007 Feb; 65(2):357-62. PubMed ID: 17302284
[TBL] [Abstract][Full Text] [Related]
17. Abass Alavi: A giant in Nuclear Medicine turns 80 and is still going strong!
Høilund-Carlsen PF
Hell J Nucl Med; 2018; 21(1):85-87. PubMed ID: 29550853
[TBL] [Abstract][Full Text] [Related]
18. Positron emission tomographic imaging in drug discovery.
Ghosh KK; Padmanabhan P; Yang CT; Ng DCE; Palanivel M; Mishra S; Halldin C; Gulyás B
Drug Discov Today; 2022 Jan; 27(1):280-291. PubMed ID: 34332093
[TBL] [Abstract][Full Text] [Related]
19. Positron-emission tomography molecular imaging of glia and myelin in drug discovery for multiple sclerosis.
Matthews PM; Datta G
Expert Opin Drug Discov; 2015 May; 10(5):557-70. PubMed ID: 25843125
[TBL] [Abstract][Full Text] [Related]
20. The role of positron emission tomography in the discovery and development of new drugs; as studied in laboratory animals.
Roselt P; Meikle S; Kassiou M
Eur J Drug Metab Pharmacokinet; 2004; 29(1):1-6. PubMed ID: 15151164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
